Cargando…

Herpes virus seroepidemiology in the adult Swedish population

BACKGROUND: Herpes viruses establish a life-long latency and can cause symptoms during both first-time infection and later reactivation. The aim of the present study was to describe the seroepidemiology of Herpes simplex type 1 (HSV1), Herpes simplex type 2 (HSV2), Cytomegalovirus (CMV), Varicella Z...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Jan, Kok, Eloise, Adolfsson, Rolf, Lövheim, Hugo, Elgh, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424393/
https://www.ncbi.nlm.nih.gov/pubmed/28491117
http://dx.doi.org/10.1186/s12979-017-0093-4
_version_ 1783235126229991424
author Olsson, Jan
Kok, Eloise
Adolfsson, Rolf
Lövheim, Hugo
Elgh, Fredrik
author_facet Olsson, Jan
Kok, Eloise
Adolfsson, Rolf
Lövheim, Hugo
Elgh, Fredrik
author_sort Olsson, Jan
collection PubMed
description BACKGROUND: Herpes viruses establish a life-long latency and can cause symptoms during both first-time infection and later reactivation. The aim of the present study was to describe the seroepidemiology of Herpes simplex type 1 (HSV1), Herpes simplex type 2 (HSV2), Cytomegalovirus (CMV), Varicella Zoster virus (VZV) and Human herpes virus type 6 (HHV6) in an adult Swedish population (35–95 years of age). METHODS: Presence of antibodies against the respective viruses in serum from individuals in the Betula study was determined with an enzyme-linked immunosorbent assay (ELISA). Singular samples from 535 persons (53.9% women, mean age at inclusion 62.7 ± 14.4 years) collected 2003-2005 were analyzed for the five HHVs mentioned above. In addition, samples including follow-up samples collected 1988–2010 from 3,444 persons were analyzed for HSV. RESULTS: Prevalence of HSV1 was 79.4%, HSV2 12.9%, CMV 83.2%, VZV 97.9%, and HHV6 97.5%. Herpes virus infections were more common among women (p = 0.010) and a lower age-adjusted HSV seroprevalence was found in later birth cohorts (p < 0.001). The yearly incidence of HSV infection was estimated at 14.0/1000. CONCLUSION: Women are more often seropositive for HHV, especially HSV2. Age-adjusted seroprevalence for HSV was lower in later birth cohorts indicating a decreasing childhood and adolescent risk of infection.
format Online
Article
Text
id pubmed-5424393
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54243932017-05-10 Herpes virus seroepidemiology in the adult Swedish population Olsson, Jan Kok, Eloise Adolfsson, Rolf Lövheim, Hugo Elgh, Fredrik Immun Ageing Research BACKGROUND: Herpes viruses establish a life-long latency and can cause symptoms during both first-time infection and later reactivation. The aim of the present study was to describe the seroepidemiology of Herpes simplex type 1 (HSV1), Herpes simplex type 2 (HSV2), Cytomegalovirus (CMV), Varicella Zoster virus (VZV) and Human herpes virus type 6 (HHV6) in an adult Swedish population (35–95 years of age). METHODS: Presence of antibodies against the respective viruses in serum from individuals in the Betula study was determined with an enzyme-linked immunosorbent assay (ELISA). Singular samples from 535 persons (53.9% women, mean age at inclusion 62.7 ± 14.4 years) collected 2003-2005 were analyzed for the five HHVs mentioned above. In addition, samples including follow-up samples collected 1988–2010 from 3,444 persons were analyzed for HSV. RESULTS: Prevalence of HSV1 was 79.4%, HSV2 12.9%, CMV 83.2%, VZV 97.9%, and HHV6 97.5%. Herpes virus infections were more common among women (p = 0.010) and a lower age-adjusted HSV seroprevalence was found in later birth cohorts (p < 0.001). The yearly incidence of HSV infection was estimated at 14.0/1000. CONCLUSION: Women are more often seropositive for HHV, especially HSV2. Age-adjusted seroprevalence for HSV was lower in later birth cohorts indicating a decreasing childhood and adolescent risk of infection. BioMed Central 2017-05-10 /pmc/articles/PMC5424393/ /pubmed/28491117 http://dx.doi.org/10.1186/s12979-017-0093-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Olsson, Jan
Kok, Eloise
Adolfsson, Rolf
Lövheim, Hugo
Elgh, Fredrik
Herpes virus seroepidemiology in the adult Swedish population
title Herpes virus seroepidemiology in the adult Swedish population
title_full Herpes virus seroepidemiology in the adult Swedish population
title_fullStr Herpes virus seroepidemiology in the adult Swedish population
title_full_unstemmed Herpes virus seroepidemiology in the adult Swedish population
title_short Herpes virus seroepidemiology in the adult Swedish population
title_sort herpes virus seroepidemiology in the adult swedish population
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424393/
https://www.ncbi.nlm.nih.gov/pubmed/28491117
http://dx.doi.org/10.1186/s12979-017-0093-4
work_keys_str_mv AT olssonjan herpesvirusseroepidemiologyintheadultswedishpopulation
AT kokeloise herpesvirusseroepidemiologyintheadultswedishpopulation
AT adolfssonrolf herpesvirusseroepidemiologyintheadultswedishpopulation
AT lovheimhugo herpesvirusseroepidemiologyintheadultswedishpopulation
AT elghfredrik herpesvirusseroepidemiologyintheadultswedishpopulation